Viking Therapeutics, Inc.
VKTX
$23.94
$0.341.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 902.61M | 930.44M | 942.26M | 962.98M | 362.08M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.13M | 1.73M | 138.00K | 643.00K | 2.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.48M | 4.48M | 3.32M | 2.72M | 2.62M |
| Total Current Assets | 907.22M | 936.65M | 945.72M | 966.34M | 367.23M |
|
|
|||||
| Total Current Assets | 907.22M | 936.65M | 945.72M | 966.34M | 367.23M |
| Net Property, Plant & Equipment | 1.00M | 1.11M | 977.00K | 1.05M | 1.13M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 102.00K | 126.00K | 138.00K | 131.00K | 139.00K |
| Total Assets | 908.32M | 937.89M | 946.84M | 967.52M | 368.49M |
|
|
|||||
| Total Accounts Payable | 9.81M | 254.00K | 11.09M | 5.23M | 7.51M |
| Total Accrued Expenses | 17.11M | 24.95M | 13.67M | 27.22M | 11.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 489.00K | 480.00K | 334.00K | 329.00K | 324.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 27.41M | 25.69M | 25.09M | 32.77M | 19.14M |
|
|
|||||
| Total Current Liabilities | 27.41M | 25.69M | 25.09M | 32.77M | 19.14M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 630.00K | 755.00K | 766.00K | 852.00K | 936.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 28.04M | 26.44M | 25.86M | 33.63M | 20.07M |
|
|
|||||
| Common Stock & APIC | 1.37B | 1.36B | 1.35B | 1.34B | 733.55M |
| Retained Earnings | -487.91M | -452.49M | -427.55M | -405.30M | -377.94M |
| Treasury Stock & Other | -788.00K | 1.63M | -2.27M | -1.60M | -7.18M |
| Total Common Equity | 880.28M | 911.45M | 920.98M | 933.89M | 348.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 880.28M | 911.45M | 920.98M | 933.89M | 348.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 880.28M | 911.45M | 920.98M | 933.89M | 348.42M |
|
|
|||||